P. Shakib, Shirzad Fallahi, G. Goudarzi, Shahram Ahmadi Somaghian, Sana Amiri, Sirus Nemati Delfan, Kourosh Cheraghipour
{"title":"Antifungal Activity of Chitosan Nanocomposites against Candida albicans:\nA Systematic Review","authors":"P. Shakib, Shirzad Fallahi, G. Goudarzi, Shahram Ahmadi Somaghian, Sana Amiri, Sirus Nemati Delfan, Kourosh Cheraghipour","doi":"10.2174/0115734072297928240404074703","DOIUrl":null,"url":null,"abstract":"\n\nThis investigation aims to explore the potential anti-Candida albicans\neffects of Chitosan nanocomposites.\n\n\n\nResearchers searched several databases, including Scopus, PubMed, Science Direct,\nCochrane, and Ovid, for articles published between 2000 and 2023 using specific keywords.\n\n\n\nOf the 5,600 studies that were first searched in the databases, after removing duplicates\n(700 cases) and applying inclusion and exclusion criteria, 43 studies were selected for evaluation\nafter duplicate removal.\n\n\n\nAccording to studies, the anti-Candida albicans properties of chitosan nanocomposites\nare more than routine antifungals such as nystatin; therefore, it can be concluded that Chitosan\nnanocomposites can be used to deal with Candida albicans.\n","PeriodicalId":10772,"journal":{"name":"Current Bioactive Compounds","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioactive Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115734072297928240404074703","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
This investigation aims to explore the potential anti-Candida albicans
effects of Chitosan nanocomposites.
Researchers searched several databases, including Scopus, PubMed, Science Direct,
Cochrane, and Ovid, for articles published between 2000 and 2023 using specific keywords.
Of the 5,600 studies that were first searched in the databases, after removing duplicates
(700 cases) and applying inclusion and exclusion criteria, 43 studies were selected for evaluation
after duplicate removal.
According to studies, the anti-Candida albicans properties of chitosan nanocomposites
are more than routine antifungals such as nystatin; therefore, it can be concluded that Chitosan
nanocomposites can be used to deal with Candida albicans.
Current Bioactive CompoundsPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.90
自引率
0.00%
发文量
112
期刊介绍：
The journal aims to provide comprehensive review articles on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia. The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
